MULTIFOCAL MOTOR NEUROPATHY (MMN)
Clinical trials for MULTIFOCAL MOTOR NEUROPATHY (MMN) explained in plain language.
Never miss a new study
Get alerted when new MULTIFOCAL MOTOR NEUROPATHY (MMN) trials appear
Sign up with your email to follow new studies for MULTIFOCAL MOTOR NEUROPATHY (MMN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to replace IVIg for nerve disease
Disease control OngoingThis study tests if a new drug, empasiprubart, works as well as standard IVIg treatment for adults with multifocal motor neuropathy (MMN), a condition that causes muscle weakness. About 154 people who have responded to IVIg in the past will be randomly assigned to receive either …
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug aims to keep rare nerve disease in check long-term
Disease control OngoingThis study is a long-term follow-up for people with multifocal motor neuropathy, a rare condition that causes muscle weakness. It tests the safety and effectiveness of a drug called ARGX-117, given intravenously. The trial includes 51 adults who previously took part in an earlier…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC